May 29, 2024 07:00AM
Sep 28, 2023 07:00AM
May 31, 2023 07:00AM
May 19, 2022 12:06PM
May 19, 2022 12:06PM
May 16, 2022 04:51PM
May 16, 2022 04:49PM Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest
May 16, 2022 04:49PM
May 11, 2022 04:15PM
May 11, 2022 04:15PM
May 5, 2022 12:03PM
May 5, 2022 12:03PM
May 5, 2022 08:04AM
May 5, 2022 08:00AM Athira Mails Letter to Shareholders Emphasizing the Company’s Strong Position and Qualified Board as it Enters Pivotal Chapter
May 5, 2022 08:00AM
May 4, 2022 06:46PM
May 4, 2022 06:46PM
Apr 26, 2022 08:00AM
Apr 26, 2022 08:00AM
Apr 20, 2022 09:04AM
Apr 20, 2022 09:02AM Athira Mails Letter to Shareholders Highlighting the Strength of its Board and Record of Deliberate Board Refreshment
Apr 20, 2022 09:02AM
Apr 5, 2022 04:04PM
Apr 5, 2022 04:04PM
Dec 15, 2021 04:42AM
May 26, 2021 07:00AM
May 26, 2021 07:00AM
Mar 10, 2021 07:07AM Athira Pharma (ATHA) Management Meeting Takeaways - Goldman Sachs
Feb 10, 2021 04:05PM
Feb 10, 2021 04:05PM
Jan 21, 2021 05:56AM
Jan 20, 2021 07:35PM
Jan 20, 2021 07:35PM
Jan 19, 2021 08:00AM
Jan 19, 2021 07:59AM Athira Pharma Announces Proposed Public Offering of Common Stock
Jan 19, 2021 07:59AM
Sep 22, 2020 04:05PM
Sep 22, 2020 04:05PM
Sep 18, 2020 12:04PM
Sep 18, 2020 05:53AM
Sep 17, 2020 08:21PM
Sep 17, 2020 08:21PM Athira Pharma Announces Pricing of Initial Public Offering

176,323 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All